Page results
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
UCLH Find & Treat team explain why screening is vital on World Hepatitis Day
-
Introduction Fatigue is a common and invisible symptom that is not always obvious to others such as partners, family members, friends or colleagues. As a result others may not understand the…
-
What does the staff experience team do? The Staff Experience team brings many amazing initiatives to our hardworking teams across UCLH. We’ve delivered the Be Well programme to support health…
-
November is men’s health month (Movember), we are hosting our first public Live Q&A event via MS Teams.
-
The support and information specialists were shortlisted for a self-care innovation award. The award recognises the achievements of the team in developing and delivering a package of support for…
-
What is malaria? Malaria is an important cause of fever in travellers returning from Africa, Asia and South America. It is an infection caused by the malaria parasite (Plasmodium), which is…
